<DOC>
	<DOCNO>NCT00337571</DOCNO>
	<brief_summary>This study compare effectiveness ( well drug work ) aripiprazole placebo ( fix dose ) reduce serious behavioral problem child adolescent diagnosis autistic disorder ( AD ) .</brief_summary>
	<brief_title>Study Aripiprazole Treatment Children Adolescents With Autistic Disorder ( AD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Behavioral Symptoms</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Meets current Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) diagnostic criterion AD demonstrate serious behavioral problem ; diagnosis confirm Autism , Diagnostic InterviewRevised ( ADIR ) . CGI score &gt; = 4 AND ABC Irritability/Agitation subscale score &gt; = 18 screening baseline ( randomization ) Mental age least 18 month Male female 6 17 year age inclusive , time randomization Patients consider treatment resistant neuroleptic medication base lack therapeutic response 2 different neuroleptic treatment least 3 week Patients previously treat respond aripiprazole treatment The patient currently diagnose another disorder autism spectrum , include PDDNOS , Asperger 's Disorder , Rett 's Disorder , FragileX Syndrome Childhood Disintegrative Disorder Current diagnosis bipolar disorder , psychosis , schizophrenia , major depression A seizure past year History severe head trauma stroke Nonpharmacologic therapy ( e.g. , psychotherapy , behavior modification ) stable prior screening consistent throughout study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Serious behavioral problem child adolescent AD</keyword>
</DOC>